Status | Study |
Recruiting |
Study Name: Study of Efficacy and Safety of Osilodrostat in Cushing's Syndrome Condition: Cushing's Syndrome Ectopic Corticotropin Syndrome Adrenal Date: 2015-06-08 Interventions: Drug: Osilodrostat Osilodrostat will be prescribed by the investigator. Osirodrostat 1 mg, 5 mg, 10 mg, |
Recruiting |
Study Name: Surgery of Subclinical Cortisol Secreting Adrenal Incidentalomas Condition: Adrenal Incidentalomas Date: 2015-01-28 Interventions: Procedure: Laparoscopic surgical removal of the adrenal tumor |
Recruiting |
Study Name: Structured Evaluation of adRENal Tumors Discovered Incidentally - Prospectively Investigating the Testing Yield Condition: Adrenal Incidentaloma Adrenocortical Carcinoma Date: 2014-12-19 |
Completed |
Study Name: Medical Safety Follow-up Study for Patients Who Received More Than 28 Days of Total Exposure to BGG492 Condition: Adrenocortical Adenoma Endometrial Stromal Sarcomas Date: 2014-05-15 Interventions: Procedure: MRI, CT or ultrasound was permitted if MRI was contraindicated |
Active, not recruiting |
Study Name: Laparoscopic Adrenalectomy Versus Radiofrequency Ablation Condition: Hyperaldosteronism Conn Syndrome Adrenocortical Adenoma Date: 2014-01-05 Interventions: Procedure: Radiofrequency Ablation Procedu |
Completed |
Study Name: Natural History and Tissue Acquisition Study of Adrenocortical Carcinoma Condition: Adrenocortical Carcinoma Date: 2013-12-13 |
Recruiting |
Study Name: Effect of Chronic Catecholamine Overproduction on Brown Adipose Tissue Condition: Pheochromocytoma Adrenal Incidentaloma Date: 2013-09-20 Interventions: Procedure: Removal of adrenal tumor |
Recruiting |
Study Name: Phase 1 Study of ATR-101 in Subjects With Advanced Adrenocortical Carcinoma Condition: Adrenocortical Carcinoma Adrenal Cancer ACC Date: 2013-07-10 Interventions: Drug: ATR-101 |
Active, not recruiting |
Study Name: Surgery and Heated Chemotherapy for Adrenocortical Carcinoma Condition: Adrenocortical Carcinoma Peritoneal Carcinomatosis Date: 2013-04-12 Interventions: Drug: Cisplatin Patients who a |
Terminated |
Study Name: Possible New Therapy for Advanced Cancer Condition: Adrenocortical Carcinoma Date: 2012-09-11 Interventions: Drug: IL-13-PE IL-13-PE intravenous infusion Other N |